comparemela.com

Latest Breaking News On - Rakesh jhunjhunwala - Page 1 : comparemela.com

From Savitri Jindal to Falguni Nayar: A look at the top 10 richest women billionaires in India

From Savitri Jindal to Falguni Nayar: A look at the top 10 richest women billionaires in India
financialexpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialexpress.com Daily Mail and Mail on Sunday newspapers.

India
Lucknow
Uttar-pradesh
Savitri-jindal
Radha-vembu
Kiran-mazumdar-shaw
Mukesh-ambani
Leena-tewari
Smita-crishna-godrej
Nirmala-sitharaman
Micky-jagtiani
Arijit-singh

Rekha Rakesh Jhunjhunwala earns ₹224 crore dividend from portfolio in March quarter

Rekha Rakesh Jhunjhunwala earns ₹224 crore dividend from portfolio in March quarter
hindustantimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from hindustantimes.com Daily Mail and Mail on Sunday newspapers.

Canara
Karnataka
India
Mumbai
Maharashtra
Rekha-jhunjhunwala
Rakesh-jhunjhunwala
Rekha-rakesh-jhunjhunwala
Titan-company
Canara-bank
Geojit-financial-services
Tata-motors

Afternoon brief: Manmohan Singh's sharp attack on PM Modi; ED attaches properties in Noida mall, more news

A shortlist of the biggest headlines, recommended stories, and a special collection of news items you should check out. | Latest News India

Mumbai
Maharashtra
India
Russia
Delhi
Hong-kong
Ukraine
Rekha-rakesh-jhunjhunwala
Arvind-kejriwal
Chhota-rajan
Manmohan-singh
Lok-sabha

Rekha Rakesh Jhunjhunwala Earns Rs 224 Crore As Dividend In Q4 From Rs 38,000 Crore Portfolio

Rekha Jhunjhunwala, wife of late ace investor Rakesh Jhunjhunwala, has likely earned a dividend income of Rs 224 crore

Canara
Karnataka
India
Rakesh-jhunjhunwala
Rekha-jhunjhunwala
Tata-motors
Titan-company
Geojit-financial-services
Canara-bank
Valor-estate
Escorts-kubota
Fortis-healthcare

Concord Biotech rallies 8% as Kotak upgrades stock to 'add', sees 11% upside

After an impressive 220 bps EBITDA margin expansion in FY24, Concord is guiding for further improvement in FY25/26.

Rakesh-jhunjhunwala
Ontario-inc
Concord-biotech
Kotak-institutional-equities

vimarsana © 2020. All Rights Reserved.